Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of infliximab in Chinese patients with moderate-to-severe plaque-type psoriasis has completed. Results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-17